Related Experiment Video
Updated: Dec 22, 2025
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.8K
Summary of Oncologic and Functional Outcomes
1Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Clinics in Colon and Rectal Surgery
|May 1, 2020
Summary
Transanal total mesorectal excision shows short-term oncological outcomes comparable to laparoscopic surgery. Further randomized trials are needed to confirm these findings and evaluate long-term functional results and quality of life.
Area of Science:
- Colorectal surgery
- Surgical oncology
- Minimally invasive procedures
Background:
- Transanal total mesorectal excision (TaTME) is an emerging minimally invasive technique for rectal cancer.
- Initial studies suggest oncological safety comparable to traditional laparoscopic surgery.
Purpose of the Study:
- To evaluate the short-term oncological outcomes of transanal total mesorectal excision.
- To highlight the need for further research into functional outcomes and quality of life.
Main Methods:
- Analysis of large cohort and collaborative studies.
- Ongoing randomized controlled trials (GRECCAR 11, COLOR III) are referenced.
Main Results:
- Short-term oncological outcomes of TaTME appear to be at least as good as laparoscopic surgery.
- Limited functional data is currently available.
Conclusions:
- TaTME demonstrates promising short-term oncological safety.
- Randomized controlled trials are crucial for validating these results.
- More mature data on quality of life and functional outcomes are needed.
Related Concept Videos
01:21Cancer Survival Analysis
584
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
584
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
01:20Comparing the Survival Analysis of Two or More Groups
488
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
488
01:12Loss of Tumor Suppressor Gene Functions
5.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K